Skip to main content

NTL (Lapatinib 250 mg)

Pill with imprint NTL is Orange, Elliptical / Oval and has been identified as Lapatinib 250 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Lapatinib is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Lapatinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NTL

Lapatinib

Imprint
NTL
Strength
250 mg
Color
Orange
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Egfr inhibitors, Her2 inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
Manufacturer
Natco Pharma Limited
National Drug Code (NDC)
68180-0801

Get help with Imprint Code FAQs.

Related Images for "NTL"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.